DexCom Inc - Product Pipeline Analysis, 2019 Update - ResearchAndMarkets.com

The "DexCom Inc (DXCM) - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

Dexcom Inc (Dexcom) is a medical device company that performs design, development and commercialization of continuous glucose monitoring (CGM) systems. The company's major products include integrated CGM systems for adults and pediatric use, insulin pumps, associated software and mobile apps. It provides Dexcom Care training to users of CGM system and other support services. The company offers products to endocrinologists, physicians, diabetes educators and others. It distributes products in the North America, Asia, Latin America and the Middle East through direct sales force and a network of distributors. Dexcom is headquartered in San Diego, California, the US.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company DexCom Inc
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

• DexCom Inc Company Overview
• DexCom Inc Company Snapshot
• DexCom Inc Pipeline Products and Ongoing Clinical Trials Overview
• DexCom Inc - Pipeline Analysis Overview
• Business Description
• DexCom Inc - Key Facts
• DexCom Inc - Major Products and Services
• DexCom Inc Pipeline Products by Development Stage
• DexCom Inc Ongoing Clinical Trials by Trial Status
• DexCom Inc Pipeline Products Overview
• DexCom CGM With Accu-Chek Insulin Delivery System
• DexCom CGM With Accu-Chek Insulin Delivery System Product Overview
• Dexcom CGM With Smart Insulin Delivery
• Dexcom CGM With Smart Insulin Delivery Product Overview
• Dexcom G6 Pro Continuous Glucose Monitoring System
• Dexcom G6 Pro Continuous Glucose Monitoring System Product Overview
• Dexcom G7 CGM System
• Dexcom G7 CGM System Product Overview
• Dexcom G7 CGM System Clinical Trial
• First-Gen Verily Sensor
• First-Gen Verily Sensor Product Overview
• inControl
• inControl Product Overview
• inControl Clinical Trial
• Touchscreen Receiver
• Touchscreen Receiver Product Overview
• DexCom Inc - Key Competitors
• DexCom Inc - Key Employees
• DexCom Inc - Key Employee Biographies
• DexCom Inc - Locations And Subsidiaries
• Head Office
• Other Locations & Subsidiaries
• Recent Developments
• DexCom Inc, Recent Developments
• Nov 06, 2019: Dexcom reports third quarter 2019 financial results
• Nov 04, 2019: Walgreens provides faster, more convenient access to continuous glucose monitoring devices through new medicare billing solution
• Oct 08, 2019: Dexcom Announces FDA Clearance of New Dexcom G6 Pro CGM
• Sep 17, 2019: Dexcom promotes Quentin Blackford to Chief Operating Officer
• Sep 17, 2019: Dexcom appoints Bridgette Heller to Board of Directors
• Sep 09, 2019: JDRF celebrates the announcement of Dexcom G6 CGM System's Availability in Canada
• Aug 23, 2019: Court rules that the patents asserted against Dexcom CGM systems are invalid
• Jul 31, 2019: Dexcom reports second quarter 2019 financial results
• Jun 06, 2019: Dexcom and Companion Medical announce collaboration to integrate Dexcom CGM data and InPen insulin data
• May 01, 2019: Dexcom reports first quarter 2019 financial results
• Appendix
• Methodology
• About the Author
• Contact Us
• Disclaimer

Companies Mentioned

• Becton Dickinson and Co
• Ascensia Diabetes Care US Inc
• LifeScan Inc
• Abbott Diabetes Care Inc
• Medtronic Diabetes

For more information about this company profile visit https://www.researchandmarkets.com/r/7h6svd

View source version on businesswire.com: https://www.businesswire.com/news/home/20200124005245/en/